Cannabis advocates throughout the US are anticipating another green wave in the upcoming elections of November 2020. Earlier, this wave had swept the nation in 2016, where eight out of nine states legalized cannabis in their respective jurisdictions. What will voting for cannabis legalization hold for the future of states who have popped the big question on their November ballots?
Cannabis Legalization Voting in 2020
This year, the decision of legalizing marijuana is going to be placed before voters of five different states in the United States. If the results turn out in favor of the cannabis industry, the sector can be expected to experience some impeccable growth in the future.
With global legalization talks already on the forefront, the CBD market is expected to reach $2.1 billion in consumer sales by the end of 2020 according to Hemp Business Journal.
Other opportunities like recreational expansion of CBD among older populations, increase in medical testing and addition of CBD into a variety of products, mean that there is a niche in the market for many new ventures.
The effect cannabis legalization on the US economy is heavily dependent upon voters’ choice in the November elections. Here is an overview of the states that are going to put the measure on their ballots for voter’s verdict.
In 2016, Arizona’s initiative to legalize marijuana had failed by a small percentage. Out of the total number of votes cast, 48.7% voted in favor of the legalization, putting the percentage of the opponents of the imitative at 51.3%.
This year, Proposition 207 has made it to the ballots again as another legalization effort. Under this Smart and Safe Arizona Act, possession, use and cultivation of marijuana in limited quantities would be permitted by law to adults 21 and older. An additional provision made under the Act is the expungement of past marijuana offense records of individuals.
Industry publications by Marijuana Business Daily estimates recreational sales in the state to reach between $700 million to $760 million by 2024.
Opposition by critics of marijuana legalization in the state include names like Governor Doug Ducey, Arizona Chamber of Commerce and Smart Approaches to Marijuana.
As opposed to this, some prominent names of the cannabis industry are backing the recreational initiative of Proposition 207. Curaleaf, Harvest Health & Recreation and Cresco Labs are a few of them.
Success of legalization efforts in New Jersey will have rippling effects on its neighboring states of New York and New Jersey. The decriminalizing of limited quantities of marijuana and halting arrests relating to marijuana crimes imply social justice reforms that the state has already put in place.
According to DeVaughn of Marijuana Policy Project, “At two ounces, it would still be progress for the region. The reality is that for every increase is another life that could potentially be saved; somebody that could not be forced to encounter law enforcement.”
The cannabis legalization initiative known as Public Question No.1, will legalize marijuana for adults 21 and older in the state. The same commission that oversees the states medical cannabis businesses will manage the initiative upon success.
According to the estimates of Marijuana Business Daily, the recreational cannabis market would generate between $850 million and $950 million by 2024. A state sales tax amounting to 6.625% will be applied on the products.
South Dakota is going to be unique participant of the cannabis legalization voting of November elections. This is because usually most states adopt some form of medical cannabis legalization before moving towards the recreational sector.
Unlike this conventional attitude, South Dakota is asking voter’s verdict on both medicinal and recreational marijuana programs under Measure 26. The initiative will make individuals with debilitating medical conditions eligible for a medical cannabis program and a registration system.
An additional marijuana initiative called Constitutional Amendment A is also on the ballot. This will legalize cannabis for all adults and require state legislators to adopt medical cannabis and hemp laws. By the fiscal year of 2024, $29.3 million in may be generated in tax revenue in the state.
Sales estimates are not yet available.
Like South Dakota, voters in Montana will also see two cannabis initiatives on their ballots. I-90 is related to the possession, purchase and use of cannabis for recreational use. The other initiative, CI-118, would regard 21 as the minimum legal age to carry out activities listed in I-90.
The tax on recreational cannabis would be 20%. In addition, individuals serving a sentence for previous cannabis related crimes would have their cases reviewed. This will also include expungments of past records.
If voters favor the initiative, recreational sales in the state could reach $193 million in 2025. Furthermore, the tax revenue could be $38.5 million in the state.
Initiative 65 in Mississippi made it to the ballots as a result of a petition filed by a citizen. Under its provisions, physicians could prescribe medical cannabis to patients with 22 types of ailments. These include various types of cancer, multiple sclerosis and PTSD.
Initiative 65A is another marijuana initiative in the Mississippi ballots. Under this competing measure, cannabis medical products should be of pharmaceutical grade. In addition to this, the quantity of cannabis that can be used by the terminally put under diminution. Furthermore, any the right to make amendments in the present regulations, will rest with the legislature under this initiative.
According to the estimates of Marijuana Business Daily, Initiative 65 would generate medical sales between $750 million to $800 million by 2024.
Cannabis Home Delivery Services Likely to commence in Massachusetts
The CCC has agreed upon setting up a substructure for beginning cannabis home delivery services in the state of Massachusetts. The organization has presented a draft highlighting a timeline and new industry rules for starting the delivery services. Operations may begin in about a month.
The Commission has proposed an outline that would permit two types of delivery licenses for operators. Its limited delivery license would allow authorized personnel to make deliveries from CCC licensed retailers and dispensaries. Furthermore, the wholesale delivery license would allow operators to buy cannabis in wholesale directly from the cultivators. The purchased commodities will be allowed storage at a CCC approved warehouse facility. Warehouses are required to have a docking facility or sally port for a secure loading of delivery vehicles.
In additio.3n to these requirements, the CCC’s delivery draft regulations has fixed a $1,500 application fee for the licenses. Along with this, a $5,000 annual license fee for limited delivery licensees and a $10,000 annual license fee for wholesale delivery licensees is also proposed. As per the initial drafts, the CCC has decided to relinquish the application fee and first year license fee for limited delivery licensees. In the second year, the fees will be halved.
Chairman Steven Hoffman has pushed the Commission to provide finalized delivery regulations by October 20th. In the light of this, the CCC will shortly open a public comment period on the delivery regulations.
What would these cannabis delivery licenses mean for licentiate?
These delivery permits would allow licensees to supplement retail stores and provide new channels of recreational marijuana purchase.. Obtaining delivery licenses would provide a boost to small businesses. This is because the barriers to obtaining retail licenses are much more pronounced than the delivery category.
According to Commissioner Britte McBride, who wrote the regulations, “What we’ve done in addition to creating those two license types is also to establish new fees and fee structures, to require warehousing for wholesale delivery licensees, to authorize white labeling for wholesale delivery licensees. We’re defining specific operational requirements that will be in addition to the general operational requirements, and we are amending existing relevant regulations to incorporate the license types and the activities that they can undertake,”
Is it too early to allow cannabis home delivery services?
Is the requisition of cannabis really going to be just a phone call away?
For marijuana opponents, the idea of getting such convenient doorstep delivery is surely not going to be taken in good spirits. According to ballotpedia, about 46.34% of voters in Massachusetts were against the legalization of marijuana and its regulation as alcohol in 2016. For this particular segment of the population, home delivery of the drug may be an advancement that is taking place too fast. There will be concerns related to identity thefts, rise in crime rates, and products falling into wrong hands, particularly children.
Contrary to this, for the advocates of marijuana, this advancement of licenses would allow them a much needed convenience. Look at this from the perspective of bed-ridden medical marijuana patients. Leaving beds, let alone houses, is a painful endeavor for this segment of marijuana users. If other medications are already being delivered to their doorsteps, why cant medicinal marijuana join the delivery market?
For the recreational users, home deliveries might prove catalytic in reducing the stigma attached to marijuana usage. For years, marijuana has been shelled with the “not in my backyard” attitude. Despite of being advocates, most marijuana users have had to hide their association with the drug to curtail themselves from the society. If home delivery vans arrive right at the door step, it may lead to a normalization and acceptance of marijuana at some point.
Why allow delivery now?
Delivery of medical marijuana is not a new concept, even in the state of Massachusetts. Almost six authorized medical dispensaries have provided this service to registered patients since 2018.
If more licenses are granted for more legal businesses, illegal delivery services may be controlled right in infancy. In addition, this will also provide low cost business opportunities to aspiring market entrants.
The government provides no support to the marijuana industry due to its illegal federal status. By creating such opportunities at the state level, barriers to entry may be successfully reduced.
Study Shows No Significant Mental Effects In Elderly Patients Using Medicinal Cannabis For Chronic Pains
The elderly, often subjected to various medical conditions, need therapies and treatments as much as any other age group. Yet unfortunately, some point out that the field sometimes doesn’t get as much attention as younger groups. That may explain why pediatric doctors greatly outnumber geriatric specialists. And then, there does exist the tendency for the elderly to be more likely to be dismissed, compared to younger patients. Regardless, one of the most common aliments in the elderly is that of chronic pain in different parts of their aged bodies. Luckily, medicinal cannabis may hold the solution for them, as numerous experts find its properties useful for old people.
A recent study from Israel set out to ascertain whether or not weed would harmfully affect the cognitions of a sample of aged individuals. The participants included both middle-aged individuals and the elderly ones, as both seemed likely to have chronic pains. Furthermore, because the aim was to find effects on cognition, both types had fully-developed brains. What the scientists found may further the needle for the campaign to normalize medicinal cannabis.
The study set up strict controls and parameters to keep it as accurate as possible
The problem that arises with any diverse sample is the presence of individual differences. If not adjusted for, these can lead to a skewed data set and make the results questionable. In this case, the researchers strove to ensure all participants were as similar as possible. They were all above the age of 50, and no significant history with alcohol abuse or hard drugs. Some of the participants were on medicinal weed licenses, meaning they actively used it regularly. Others used it very sporadically. However, all abstained from cannabis use at least 3 hours prior. They also had similar education levels and all medically recognized as mentally sound.
The study included exactly 63 licensed individuals with the remaining 62 unlicensed. The male to female ratio was also about half and half, so sex didn’t affect the results. This almost even split served to better reproduce a normal distribution with acceptable standard deviations. Furthermore, they used a reliable software called ‘CogState’, which comprises of computerized cognitive exams. These exams covered everything required, from memory to attention spans.
The results indicated that regular cannabis use to treat chronic pains left no significant impact on cognition in the elderly
By all standards of scientific research methodology, the study mainly came out as a success. The results showed the initial hypothesis proved correct, and cannabis caused no major mental changes. In practically all participants, cognition was on par with normal levels and the frequent cannabis users did not vary much from rare users. Hence, the paper claimed that treating chronic pains with CBD (cannabidiol) and THC (tetrahydrocannabinol) would leave no lasting mental effects.
However, one interesting and alarming finding the study showed was an elevated risk of cardiovascular disease from cannabis. In addition, regular users also showed elevated frequencies of depression. The former of these may occur due to smoking cannabis rather than eating it. However, it does corroborate what a recent American Heart Association (AHA) paper claims.
While the study did have some limitations, it still shows important findings for those on the fence about medicinal weed
No truly scientific study can claim to have zero room for improvement. While they accounted for most extraneous factors, the biggest factor was the cross-sectional aspect. This means that due to broad generalizations about samples, the study cannot definitively establish cause and effect. Also, they didn’t account for previous medicinal histories.
However, the study still puts to rest many fears about brain damage from weed. For more on medicinal cannabis, stay tuned!
Why New Jersey’s Telemedicine For Prescription Cannabis Is A Big Deal
Earlier this month, legislation in New Jersey seems like it may take a turn in favor of medicinal cannabis using ‘telemedicine’. In a world, and nation, devastated by the ongoing COVID-19 pandemic, even visiting a physician may prove deadly. After all, hospitals, now overrun with emergent coronavirus cases, may become cesspools of airborne pathogens. Even healthcare providers still face significant risk of infection in their line of work. And this despite them donned in full protective gear and thoroughly disinfected regularly. As a matter of fact, going out anywhere public unnecessary remains inadvisable by the WHO and health authorities.
Recently, the members of the New Jersey state assembly convened to talk about various concerning issues. One of the biggest and most immediate issues, the plight of millions of patients needing prescription drugs at home, needing resolving. This especially held true of those requiring medicinal cannabis treatments, a drug not available at every nearby pharmacy. Therefore the members ruled to permit the use of telemedicine, a game-changing new service in the United States.
Telemedicine holds the key to quality healthcare in the middle of a dangerous pandemic
Not many outside of the medical field would immediately know what the concept refers to. Broadly speaking, telemedicine refers to any healthcare practice done without the patient and physician needing to interact in person. Looking at the etymology (the origin of the word), it’s all in the name (translating to long distance medicine). Therefore, video conferencing consultations between the patient at home and the doctor is an example of telemedicine. In addition, the purchase and delivery of prescription drugs from and to home online also counts as such.
So while it may not seem like anything more than ‘Zoom/Amazon but for medicine’, this is a gross understatement. Regular meetings, related to business, casual chatting and interviews, already occurred online before COVID-19. That classes and work began conducting over video conferences wasn’t anything unforeseeable as the pandemic grew. However, in traditional medical schools, few students receive training for how to treat patients online. After all, a good diagnosis usually comes with thorough rapport, careful inspection of the body and various examinations. So now the COVID-19 pandemic has doctors scrambling to learn an entirely new modality of work. And the concept of sitting safe at home while your lifesaving drugs come to you, risk-free is incredible.
The move comes unexpectedly, as cannabis legislation in New Jersey still holds some previous prejudices
The truth of the matter is that the United States is still a nation where recreational cannabis usage is federally illegal. And medicinal cannabis, despite modern scientific studies extolling its proven health benefits as a therapeutic agent in many conditions, as well. That means that the ‘default’ law for any state is that the drug is banned, with even possession resulting in criminal offence. The only state exceptions to this practice worked hard to exempt themselves. Even in New Jersey, recreational cannabis remains off the table, but medicinally it gained allowance.
As a result, the cannabis industry, which makes everything cannabis related (from hemp to CBD oils), doesn’t do well here. There simply isn’t a big enough market for products in states where cannabis is literally banned. In the case of New Jersey, only specially licensed dispensaries can legally sell prescription marijuana. Law makers historically have shown very little care to make medicinal weed more accessible, in addition. Furthermore, even healthcare providers may show hesitance to prescribe cannabis due to the amount of legal work required by state laws.
All in all, this move signals a step in the right direction. Hopefully, patients will receive their medications soon and safely.
Cannabis1 year ago
How CBD oil works?
Cannabis1 year ago
Research Suggests Cannabis Effective in Treating Endometriosis
Cannabis1 year ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
Health10 months ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
Featured1 year ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
Cannabis1 year ago
What are the main advantages of consuming CBD oil?
Health11 months ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
Cannabis12 months ago
Can Cannabis Survive in Pharma?